Send to a Friend Font Size: Increase Decrease

AMGN and KNBWY Related Headlines

Sep 8, 2025 08:04PM Amgen and Kyowa Kirin report one-year rocatinlimab safety data
Sep 8, 2025 08:04PM AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

AMGN and KNBWY Related Press Releases

Sep 8, 2025 08:04PM AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

AMGN and KNBWY Related SEC Filings